Proximity-Based Modalities for Biology and Medicine (2023)
Attributed to:
Development of LRRK2 PROTAC degraders as chemical probes and potential lead compounds for the treatment of Parkinson's disease
funded by
Horizon Europe Guarantee
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acscentsci.3c00395
Publication URI: http://dx.doi.org/10.1021/acscentsci.3c00395
Type: Journal Article/Review
Parent Publication: ACS Central Science
Issue: 7